Literature DB >> 9215354

Asset and Health Dynamics Among the Oldest Old: an overview of the AHEAD Study.

B J Soldo1, M D Hurd, W L Rodgers, R B Wallace.   

Abstract

This chapter provides background information for the study of Asset and Health Dynamics Among the Oldest Old (AHEAD), a prospective panel survey of persons born in 1923 or earlier who were residing in the community at the time of the 1993 baseline. Interviews were sought with both spouses in married households, and an overall total of 8,222 were completed. We review the interdisciplinary scientific issues that motivated the study, describe the fundamental design decisions that structured AHEAD, and summarize the content in the core and experimental modules. The study provides unusually detailed data on cognition, family structure and transfers, and assets. Data are presented on sample selections, response rates, and oversamples of minority groups. Basic descriptive data on the demographic, health, and socioeconomic attributes of respondents also are presented. Plans for future waves of AHEAD are described, including a next-of-kin interview for decreased respondents.

Entities:  

Mesh:

Year:  1997        PMID: 9215354     DOI: 10.1093/geronb/52b.special_issue.1

Source DB:  PubMed          Journal:  J Gerontol B Psychol Sci Soc Sci        ISSN: 1079-5014            Impact factor:   4.077


  82 in total

1.  The racial crossover in comorbidity, disability, and mortality.

Authors:  N E Johnson
Journal:  Demography       Date:  2000-08

2.  Nursing home entry in Germany and the United States.

Authors:  C L Himes; G G Wagner; D A Wolf; H Aykan; D D Dougherty
Journal:  J Cross Cult Gerontol       Date:  2000

3.  Physical disability trajectories in older Americans with and without diabetes: the role of age, gender, race or ethnicity, and education.

Authors:  Ching-Ju Chiu; Linda A Wray
Journal:  Gerontologist       Date:  2010-08-16

4.  Distal and proximal resource influences on economic dependency among the oldest old.

Authors:  Maurice MacDonald; Aradhana Aneja; Peter Martin; Jennifer Margrett; Leonard W Poon; S M Jazwinski; R C Green; M Gearing; W R Markesbery; J L Woodard; M A Johnson; J S Tenover; I C Siegler; W L Rodgers; D B Hausman; C Rott; A Davey; J Arnold
Journal:  Gerontology       Date:  2010-01-26       Impact factor: 5.140

5.  Incidence of dementia and cognitive impairment, not dementia in the United States.

Authors:  Brenda L Plassman; Kenneth M Langa; Ryan J McCammon; Gwenith G Fisher; Guy G Potter; James R Burke; David C Steffens; Norman L Foster; Bruno Giordani; Frederick W Unverzagt; Kathleen A Welsh-Bohmer; Steven G Heeringa; David R Weir; Robert B Wallace
Journal:  Ann Neurol       Date:  2011-03-18       Impact factor: 10.422

6.  Do seniors understand their risk of moving to a nursing home?

Authors:  Donald H Taylor; Jan Osterman; S Will Acuff; Truls Ostbye
Journal:  Health Serv Res       Date:  2005-06       Impact factor: 3.402

7.  Geriatric conditions develop in middle-aged adults with diabetes.

Authors:  Christine T Cigolle; Pearl G Lee; Kenneth M Langa; Yuo-Yu Lee; Zhiyi Tian; Caroline S Blaum
Journal:  J Gen Intern Med       Date:  2010-09-29       Impact factor: 5.128

8.  Development and validation of a functional morbidity index to predict mortality in community-dwelling elders.

Authors:  Elise C Carey; Louise C Walter; Karla Lindquist; Kenneth E Covinsky
Journal:  J Gen Intern Med       Date:  2004-10       Impact factor: 5.128

9.  Additive effects of cognitive function and depressive symptoms on mortality in elderly community-living adults.

Authors:  Kala M Mehta; Kristine Yaffe; Kenneth M Langa; Laura Sands; Mary A Whooley; Kenneth E Covinsky
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2003-05       Impact factor: 6.053

10.  Trajectories of cognitive function in late life in the United States: demographic and socioeconomic predictors.

Authors:  Arun S Karlamangla; Dana Miller-Martinez; Carol S Aneshensel; Teresa E Seeman; Richard G Wight; Joshua Chodosh
Journal:  Am J Epidemiol       Date:  2009-07-15       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.